Organisation paid for research Program year 2022 Source: CMS Open Payments

Benaroya Rsrch Inst

Neither a doctor nor a teaching hospital

Research payments

$317,166

62 payments

Through program year 2022, Benaroya Rsrch Inst is reported as receiving $317,166 in research payments, across 62 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$88,714	5
2021	Research	$33,920	17
2020	Research	$64,668	17
2019	Research	$129,864	23

Breakdown

Who paid Research payments · program years 2019–2022

Janssen Research & Development, LLC $317,166 62 payments

Studies the money was for Research payments · program years 2019–2022

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Study of ARN-509 in Men With Non-Metastatic (M0) Castration-Resistant Prostate Cancer $74,520 9 payments
Phase 3 Randomized Double blind Placebo controlled Parallel group Multi Center Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis $62,924 15 payments
Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis $61,003 20 payments
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of JNJ-64304500 in Subjects with Moderately to Severely Active Crohn's Disease $59,009 11 payments
A Phase 2b Randomized Double blind Placebo controlled Parallel group Multi Center Protocol to Evaluate the Safety and Efficacy of JNJ64304500 in Subjects with Moderately to Severely Active Crohn's Disease $32,568 6 payments
A Multi Center Randomized Double Blind Placebo Controlled Phase III Study of ARN509 in Men With Non Metastatic M0 Castration Resistant Prostate Cancer $27,142 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.